Johannes Streffer
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Johannes Streffer
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Johannes Streffer tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| GERON CORPORATION | Biotechnology | Corporate Officer/Principal | |
Celgene International SARL
 Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the private company is based in Boudry, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman | |
| PERSONALIS, INC. | Medical/Nursing Services | Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| SWISS LIFE HOLDING AG | Life/Health Insurance | Director/Board Member | |
| SCHINDLER HOLDING AG | Industrial Machinery | Director/Board Member | |
| HUBER+SUHNER AG | Telecommunications Equipment | Director/Board Member | |
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member | |
| University of Tilburg | College/University | Corporate Officer/Principal | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of St. Gallen | College/University | Corporate Officer/Principal | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Zurich | College/University | Undergraduate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal | |
| University of Bern | College/University | Undergraduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
HUBER+SUHNER (UK) Ltd.
 HUBER+SUHNER (UK) Ltd. Electronic Production EquipmentElectronic Technology HUBER+SUHNER (UK) Ltd. manufactures, imports, and sells electrical and optical connectivity components and accessories. It offers radio frequency and fiber optic products including antennas, assemblies, cables, connectors and adapters, lightning and EMP protectors, and resistive components. The company was founded on March 30, 1967 and is headquartered in Bicester, the United Kingdom. | Electronic Production Equipment | Director/Board Member | |
| World Demographic & Ageing Forum | Corporate Officer/Principal | ||
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
Cocomore AG
 Cocomore AG Advertising/Marketing ServicesCommercial Services Cocomore AG is a digital agency based in Frankfurt, Germany. Cocomore specializes in developing experience strategies, digital services and products, content and campaigns, and delivering IT solutions to support them. The German company aims to truly understand users and work as co-entrepreneurs with their clients to develop digital solutions that simplify life and bring businesses forward. The private company was founded in 2000 by Hans-Ulrich von Freyberg, who has been the CEO since then. | Advertising/Marketing Services | Chairman | |
| Schweizerische Management Gesellschaft | Director/Board Member | ||
| Gebert Rüf Stiftung | Corporate Officer/Principal | ||
| Network for Studies on Pensions Aging Retirement | Corporate Officer/Principal | ||
| Swiss Institute for Empirical Economic Research | Director/Board Member | ||
| Institute of Public Finance & Fiscal Law | Corporate Officer/Principal | ||
| Center for Disability & Integration | Corporate Officer/Principal | ||
| CESifo Research Network | Corporate Officer/Principal | ||
| Swiss Federal Commission for Economic Issues | Corporate Officer/Principal | ||
Aleva Neurotherapeutics SA
 Aleva Neurotherapeutics SA Electronic Equipment/InstrumentsElectronic Technology Aleva Neurotherapeutics SA develops next-generation implants for deep brain stimulation therapy. Its micro fabricated devices enable target specific stimulation and optimization of current therapies. The company was founded by Claudio Pollo, Jean-Pierre Rosat, Philipe Renaud, Paul Pyzowski and André Mercanzini and in August 2008 and is headquartered in Lausanne, Switzerland. | Electronic Equipment/Instruments | Director/Board Member | |
| Max Schmidheiny-Stiftung | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| DIMENSION THERAPEUTICS INC | Biotechnology | Director/Board Member | |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| Oxford University Medical School | College/University | Doctorate Degree | |
| Swiss Institute For Intl Economics & Applied Economic Research | Chairman | ||
| Swiss Society of Economics & Statistics | President | ||
| Richard Büchner Foundation | Director/Board Member | ||
| Blueorchard SA | Director/Board Member | ||
Heidelberg Instruments Nano AG
 Heidelberg Instruments Nano AG Information Technology ServicesTechnology Services Heidelberg Instruments Nano AG designs and develops nanolithography technology. The firm offers NanoFrazor Systems, NanoFrazor Software. NanoFrazor Cantilevers, and NanoFrazor Resists. The company was founded by Felix Holzner and Philip Paul in 2012 and is headquartered in Zurich, Switzerland. | Information Technology Services | Director/Board Member | |
| Suva City Council | Corporate Officer/Principal | ||
| ViiV Healthcare Co. | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Svizzera | 26 |
| Stati Uniti | 16 |
| Regno Unito | 4 |
| Paesi Bassi | 3 |
| Germania | 3 |
Settori
| Health Technology | 16 |
| Consumer Services | 8 |
| Finance | 4 |
| Electronic Technology | 4 |
| Commercial Services | 4 |
Posizioni
| Director/Board Member | 39 |
| Corporate Officer/Principal | 23 |
| Independent Dir/Board Member | 12 |
| Chairman | 8 |
| Founder | 4 |
Contatti più connessi
| Insiders | |
|---|---|
| Alan Colowick | 27 |
| Monika Bütler | 25 |
| Martin Velasco | 15 |
| Monica Shaw | 8 |
| Peter Bollmann | 4 |
| Howard Donovan | 2 |
- Borsa valori
- Insiders
- Johannes Streffer
- Connessioni Società
